LPA and diabetes mellitus: That we only observed an increased risk of diabetes in people with Lp(a) concentrations in the lowest two quintiles (~mean Lp(a) levels of <7 mg/dL) suggest that the use of Lp(a) lowering therapies would not be in conflict with these findings if provided therapies do not lower Lp(a) levels beyond those observed in these lowest two quintiles.